BIOTECHNOLOGY VALUE FUND L P 13D/13G Filings for iTeos Therapeutics, Inc. (ITOS)

BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for iTeos Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2024-11-21
8:27 pm
Purchase		 2024-11-14 13G iTeos Therapeutics, Inc.
ITOS		 BIOTECHNOLOGY VALUE FUND L P 2,325,000
6.400%		 1,065,524increase
(+84.60%)		 Filing
2024-02-14
09:45 am
Sale		 2023-12-31 13G iTeos Therapeutics, Inc.
ITOS		 BIOTECHNOLOGY VALUE FUND L P 1,259,476
3.500%		 -551,359decrease
(-30.45%)		 Filing
2023-02-13
6:14 pm
Sale		 2022-12-31 13G iTeos Therapeutics, Inc.
ITOS		 BIOTECHNOLOGY VALUE FUND L P 1,810,835
5.100%		 -118,366decrease
(-6.14%)		 Filing
2022-05-02
5:02 pm
Purchase		 2022-04-22 13G iTeos Therapeutics, Inc.
ITOS		 BIOTECHNOLOGY VALUE FUND L P 1,929,201
5.400%		 1,929,201increase
(New Position)		 Filing